| 摘要 |
<p>The invention relates to compounds of the general formula (I), wherein R1-R5and R2 -R4 are as described in the claimsand to pharmaceutically suitable acid additon salts, optical pure enantiomers,racemates or diastereomeric mixtures thereof for the treatment of Alzheimer sdisease or common cancers.</p> |
